How should a 6-year-old child with brief, burning episodes of anal pain lasting 20–30 seconds every 30–40 minutes, normal sigmoidoscopy and contrast‑enhanced CT abdomen, and no relief from continuous morphine and acetaminophen be managed?

Proctalgia Fugax: Discontinue Opioids and Initiate Behavioral Management

This child has proctalgia fugax, a benign functional anorectal pain syndrome that does not respond to opioids and requires immediate cessation of morphine with transition to reassurance, behavioral interventions, and consideration of celiac disease screening.

Immediate Management

Stop the morphine immediately 1. The FDA labeling for morphine IV explicitly states it is indicated only for "pain not responsive to non-narcotic analgesics" and that safety and effectiveness have not been established in pediatric patients below age 18 1. The complete lack of response to round-the-clock opioids confirms this is not opioid-responsive pain, making continued morphine administration both futile and potentially harmful.

Diagnosis: Proctalgia Fugax

The clinical presentation is pathognomonic for proctalgia fugax:

• Brief episodes (20-30 seconds) of burning anal pain
• Recurrent pattern (every 30-40 minutes)
• Spontaneous resolution
• Normal structural workup (sigmoidoscopy, CT abdomen)
• No response to analgesics

This functional anorectal pain syndrome is likely underrecognized in children 2. The brief duration and episodic nature distinguish it from chronic proctalgia, which involves longer-lasting pain episodes.

Essential Diagnostic Consideration

Screen for celiac disease with tissue transglutaminase IgA and total IgA 2. A case series documented an 8-year-old boy with recurrent anorectal cramps who was diagnosed with celiac disease, with anorectal dysfunction and visceral hypersensitivity described in celiac patients. This is a simple, non-invasive test that could identify a treatable underlying condition.

Treatment Approach

Primary Management

• Reassurance: Explain the benign, self-limited nature of proctalgia fugax to family
• Behavioral interventions: The condition often resolves spontaneously, as documented in an 8-year-old girl whose symptoms disappeared without specific treatment 2
• Topical lidocaine jelly: Continue as needed during episodes since the family reports occasional benefit

Address Constipation

Evaluate and treat any underlying constipation, which was identified as a contributing factor in pediatric cases 2. Constipation management may reduce episodes.

What NOT to Do

• Do not continue systemic opioids - they are ineffective for this functional pain syndrome and pose significant risks including respiratory depression, tolerance, and dependence 1
• Do not pursue additional invasive imaging - structural pathology has been excluded
• Avoid sphincter-based interventions - while biofeedback has been used in adults with puborectalis syndrome 3, this child's brief 20-30 second episodes are inconsistent with that diagnosis

Common Pitfalls

The major pitfall here is continuing ineffective opioid therapy for a functional pain syndrome. The morphine FDA label explicitly warns about use in pediatrics and emphasizes individualized treatment using "non-opioid analgesics, opioids on an as needed basis...in a progressive plan of pain management" 1. When opioids provide zero benefit, they must be stopped.

Another pitfall is over-investigation. The normal sigmoidoscopy and CT have already excluded structural pathology including fissures, abscesses, inflammatory bowel disease, and malignancy 4.

Expected Course

Proctalgia fugax in children often resolves spontaneously over weeks to months 2. The episodic nature and brief duration are characteristic, and the condition is benign despite being distressing to the child and family.